We are live on ! Find out more
BSA

Braun Stacey Associates Portfolio holdings

AUM $3.53B
1-Year Est. Return 63.32%
This Fund
S&P 500
This Quarter Est. Return
+8.2%
1 Year Est. Return
+63.32%
3 Year Est. Return
+230.74%
5 Year Est. Return
+346.7%
10 Year Est. Return
+1,599.29%
AUM
$2.68B
AUM Growth
+$43.8M
Cap. Flow
-$77.1M
Cap. Flow %
-2.88%
Top 10 Hldgs %
33.94%
Holding
121
New
7
Increased
28
Reduced
73
Closed
5

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$19.5M
2
CORT icon
Corcept Therapeutics
CORT
+$15.5M
3
GTLS
Chart Industries
GTLS
+$14M
4
TGTX icon
TG Therapeutics
TGTX
+$12.7M
5
EHC icon
Encompass Health
EHC
+$10.3M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$24.9M
2
APP icon
Applovin
APP
+$23.4M
3
UBER icon
Uber
UBER
+$22.7M
4
IQV icon
IQVIA
IQV
+$11.8M
5
VRT icon
Vertiv
VRT
+$10.1M

Sector Composition

Rank Sector Weight
1 Technology 29.33%
2 Financials 13.75%
3 Communication Services 12.62%
4 Consumer Discretionary 10.61%
5 Healthcare 10.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CAT icon
76
Caterpillar
CAT
$387B
$12.6M 0.47%
34,837
+963
+3% +$373K
SRPT icon
77
Sarepta Therapeutics
SRPT
$1.77B
$12.2M 0.45%
100,022
-2,990
-3% -$366K
GEV icon
78
GE Vernova
GEV
$264B
$11.8M 0.44%
35,884
-7,607
-17% -$2.38M
LIN icon
79
Linde
LIN
$226B
$11.6M 0.43%
27,700
+10
+0% +$4.56K
DKNG icon
80
DraftKings
DKNG
$11.9B
$11.2M 0.42%
302,410
+8,070
+3% +$320K
MET icon
81
MetLife
MET
$62.1B
$10.9M 0.41%
133,596
+2,410
+2% +$201K
AMGN icon
82
Amgen
AMGN
$222B
$10.9M 0.41%
41,894
-12,283
-23% -$3.64M
DY icon
83
Dycom Industries
DY
$12.3B
$10.6M 0.4%
61,091
+32,098
+111% +$5.94M
VRRM icon
84
Verra Mobility
VRRM
$744M
$10.4M 0.39%
431,714
-8,190
-2% -$203K
EHC icon
85
Encompass Health
EHC
$12.4B
$9.69M 0.36%
+104,907
New +$10.3M
CELH icon
86
Celsius Holdings
CELH
$7.03B
$7.78M 0.29%
295,257
-12,571
-4% -$373K
TKO icon
87
TKO Group
TKO
$13.6B
$5.87M 0.22%
41,286
-1,790
-4% -$234K
NYT icon
88
New York Times
NYT
$10.2B
$4.99M 0.19%
95,909
-52,581
-35% -$2.87M
DE icon
89
Deere & Co
DE
$168B
$4.59M 0.17%
10,838
-2,736
-20% -$1.15M
MS icon
90
Morgan Stanley
MS
$340B
$4.45M 0.17%
35,419
-1,655
-4% -$204K
SPY icon
91
State Street SPDR S&P 500 ETF Trust
SPY
$810B
$4.03M 0.15%
6,884
-912
-12% -$537K
PEP icon
92
PepsiCo
PEP
$190B
$3.89M 0.15%
25,604
– –
GS icon
93
Goldman Sachs
GS
$303B
$3.83M 0.14%
6,689
-200
-3% -$112K
MCD icon
94
McDonald's
MCD
$195B
$2.64M 0.1%
9,100
– –
SHW icon
95
Sherwin-Williams
SHW
$89.8B
$1.7M 0.06%
+5,000
New +$1.87M
V icon
96
Visa
V
$677B
$1.42M 0.05%
4,500
– –
MDY icon
97
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$27.1B
$1.35M 0.05%
2,362
-94
-4% -$55.1K
EXE
98
Expand Energy Corp
EXE
$21.5B
$1.3M 0.05%
13,075
-800
-6% -$73.9K
QSR icon
99
Restaurant Brands International
QSR
$25.8B
$1.06M 0.04%
16,250
-103,947
-86% -$7.21M
UBER icon
100
Uber
UBER
$153B
$1.04M 0.04%
17,207
-318,374
-95% -$22.7M
1 2 3
4
5

Similar funds

TYCC
Texas Yale Capital Corp St. Petersburg, Florida $3.52B AUM 52.63% 1-Year Est. Return
TH
TCTC Holdings Dallas, Texas $3.51B AUM 30.71% 1-Year Est. Return
AAP
Arax Advisory Partners Denver, Colorado $3.54B AUM 19.14% 1-Year Est. Return
BCP
BDT Capital Partners Chicago, Illinois $3.51B AUM 31.02% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
DILIC
Dai-ichi Life Insurance Company Tokyo, Japan $3.49B AUM 27.28% 1-Year Est. Return
KCM
Kedalion Capital Management London, United Kingdom $3.48B AUM 17.74% 1-Year Est. Return
ACM
Aquatic Capital Management Chicago, Illinois $3.48B AUM 24.9% 1-Year Est. Return

Braun Stacey Associates's Q4 2024 Portfolio in Review

As of Q4 2024, Braun Stacey Associates held 121 positions worth $2.68B, up 1.7% from $2.63B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Braun Stacey Associates's Q4 2024 filing shows 7 new, 28 increased, 73 reduced and 5 closed positions. Its largest new stake was Bristol-Myers Squibb: 348,518 shares worth $19.7M. The largest sale was Merck, an estimated $24.9M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 30% a quarter earlier, followed by Financials and Communication Services.

  • Braun Stacey Associates's largest Q4 2024 buy was Bristol-Myers Squibb: 348,518 shares worth $19.7M.
  • Braun Stacey Associates added most to Targa Resources in Q4 2024, an estimated $10.2M increase.
  • Braun Stacey Associates's biggest Q4 2024 reduction was Applovin, cutting an estimated $23.4M.
  • Braun Stacey Associates fully exited Merck in Q4 2024, selling an estimated $24.9M.
  • Braun Stacey Associates's ten largest holdings make up 34% of its $2.68B portfolio in Q4 2024.
  • Braun Stacey Associates opened 7 new positions and closed 5 in Q4 2024.
  • Braun Stacey Associates's portfolio value rose 1.7% quarter-over-quarter to $2.68B.

Based on Braun Stacey Associates's 13F filing for Q4 2024, filed 31 Jan 2025.